CPT 0413U — Oncology (hematolymphoid neoplasm), optical genome mapping for ocpy number alterations, aneuploidy, and balanced/complex structural rearrangements, DNA from blood or bone marrow, report of clinically (378 hospitals, — samples)
CPT 0414U — ONC LNG AUG ALG ALY WHL SLD8 (378 hospitals, — samples)
CPT 0418U — Oncology (breast), augmentative algorithmic analysis of digitized whole slide imaging of 8 histologic and immunohistochemical features, reported as a recurrence score (379 hospitals, — samples)
CPT 0419T — Destruction of neurofibroma, extensive (cutaneous, dermal extending into subcutaneous); face, head and neck, greater than 50 neurofibromas (410 hospitals, — samples)
CPT 0419U — NRPSYC GEN SEQ VRNT ALY 13 (387 hospitals, — samples)
CPT 0421U — Oncology (colorectal) screening, quantitative real-time target and signal amplification of 8 RNA markers and fecal hemoglobin, algorithm reported as a positive or negative for colorectal cancer risk (351 hospitals, — samples)
CPT 0422T — Tactile breast imaging by computer-aided tactile sensors, unilateral or bilateral (349 hospitals, — samples)
CPT 0422U — Oncology (pan-solid tumor), analysis of DNA biomarker response to anti-cancer therapy using cell-free circulating DNA, biomarker comparison to a previous baseline pre-treatment cell-free circulating D (254 hospitals, — samples)
CPT 0423U — Psychiatry (eg, depression, anxiety), geonomic analysis panel, including variant analysis of 26 genes, buccal swab, report including metabolizer status and risk of drug toxicity by condition (386 hospitals, — samples)
CPT 0438T — HTransperineal placement of biodegradable material, peri-prostatic (via needle), single or multiple, includes image guidance (143 hospitals, — samples)
CPT 0438U — Drug metabolism (adverse drug reactions and drug response), buccal specimen, gene-drug interactions, variant analysis of 33 genes, including deletion/duplication analysis of CYP2D6, including reported (377 hospitals, — samples)
CPT 0439U — Cardiology (Coronary Heart Disease), DNA, analysis of 5 single-nucleotide polymorphisms and 3 DNA methylation markers, qPCR and digital PCR, whole blood, algorighm reported as a 4-tiered risk score fo (230 hospitals, — samples)
CPT 0440U — CRD CHD DNA ALYS 10 SNP 6DNA (230 hospitals, — samples)
CPT 0441U — Infectious disease (bacterial, fungal or viral infection), semiquantitative biomechanical assessment, whole blood with algorighmic analysis and result reported as an Index (222 hospitals, — samples)
CPT 0442U — Infectious disease (respiratory infection), Myxovirus resistance protein A and C-reactive protein, fingerstick whole blood specimen, each biomarker reported as present or absent (386 hospitals, — samples)